Table 2.
IC50 of Fa, Fb, and CaelyxR after 48 hours of treatment.
Formulation | IC50 MCF7 (μg/mL, n = 3) |
IC50 MDA-MBA 231 (μg/mL, n = 3) |
---|---|---|
Fa | 376.45 ± 9.20 | 726.40 ± 7.58 |
Fb | 387.22 ± 6.93 | 755.73 ± 6.81 |
CaelyxR | 483.84 ± 7.78 | 972.91 ± 9.87 |
IC50 of Fa, Fb, and CaelyxR after 48 hours of treatment.
Formulation | IC50 MCF7 (μg/mL, n = 3) |
IC50 MDA-MBA 231 (μg/mL, n = 3) |
---|---|---|
Fa | 376.45 ± 9.20 | 726.40 ± 7.58 |
Fb | 387.22 ± 6.93 | 755.73 ± 6.81 |
CaelyxR | 483.84 ± 7.78 | 972.91 ± 9.87 |